Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2474114rdf:typepubmed:Citationlld:pubmed
pubmed-article:2474114lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:2474114lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2474114lifeskim:mentionsumls-concept:C0205282lld:lifeskim
pubmed-article:2474114lifeskim:mentionsumls-concept:C1413207lld:lifeskim
pubmed-article:2474114lifeskim:mentionsumls-concept:C0054941lld:lifeskim
pubmed-article:2474114lifeskim:mentionsumls-concept:C0205183lld:lifeskim
pubmed-article:2474114lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2474114lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:2474114lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:2474114pubmed:issue1lld:pubmed
pubmed-article:2474114pubmed:dateCreated1989-8-25lld:pubmed
pubmed-article:2474114pubmed:abstractTextThe authors studied the expression of CD1 and HLA-Dr antigen in benign and malignant melanic tumors to known if were the melanoma's cells or Langerhans cells, presents on the tumor, which exhibited the HLA-Dr antigens, and if the HLA-Dr expression was related to volume, depth and metastatic characteristics. These antigens were studied with the monoclonal antibodies labelled to avidin-biotin-peroxidase system. The results shows than the proportion between the number of Langerhans cells and HLA-Dr positive cells is inverse. No differences were found between the expression of the HLA-Dr antigens and number of Langerhans cells and volume, depth or metastatic characteristics.lld:pubmed
pubmed-article:2474114pubmed:languagespalld:pubmed
pubmed-article:2474114pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2474114pubmed:citationSubsetIMlld:pubmed
pubmed-article:2474114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2474114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2474114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2474114pubmed:statusMEDLINElld:pubmed
pubmed-article:2474114pubmed:issn0210-5187lld:pubmed
pubmed-article:2474114pubmed:authorpubmed-author:Castells-Rode...lld:pubmed
pubmed-article:2474114pubmed:authorpubmed-author:Valcuende-Cav...lld:pubmed
pubmed-article:2474114pubmed:authorpubmed-author:Ramírez-Bosca...lld:pubmed
pubmed-article:2474114pubmed:authorpubmed-author:Rufat-PérezM...lld:pubmed
pubmed-article:2474114pubmed:issnTypePrintlld:pubmed
pubmed-article:2474114pubmed:volume17lld:pubmed
pubmed-article:2474114pubmed:ownerNLMlld:pubmed
pubmed-article:2474114pubmed:authorsCompleteYlld:pubmed
pubmed-article:2474114pubmed:pagination58-64lld:pubmed
pubmed-article:2474114pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2474114pubmed:meshHeadingpubmed-meshheading:2474114-...lld:pubmed
pubmed-article:2474114pubmed:meshHeadingpubmed-meshheading:2474114-...lld:pubmed
pubmed-article:2474114pubmed:meshHeadingpubmed-meshheading:2474114-...lld:pubmed
pubmed-article:2474114pubmed:meshHeadingpubmed-meshheading:2474114-...lld:pubmed
pubmed-article:2474114pubmed:meshHeadingpubmed-meshheading:2474114-...lld:pubmed
pubmed-article:2474114pubmed:meshHeadingpubmed-meshheading:2474114-...lld:pubmed
pubmed-article:2474114pubmed:meshHeadingpubmed-meshheading:2474114-...lld:pubmed
pubmed-article:2474114pubmed:meshHeadingpubmed-meshheading:2474114-...lld:pubmed
pubmed-article:2474114pubmed:year1989lld:pubmed
pubmed-article:2474114pubmed:articleTitle[Expression of HLA-Dr and CD1+ cells in malignant and benign pigmentary tumors].lld:pubmed
pubmed-article:2474114pubmed:affiliationServicio de Dermatología, Hospital Clínico Universitario, Facultad de Medicina, Valencia.lld:pubmed
pubmed-article:2474114pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2474114pubmed:publicationTypeEnglish Abstractlld:pubmed